SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-99 Cr | ₹-71 Cr | ₹-33 Cr | ₹-13 Cr | ₹-14 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-99 Cr |
| Mar2024 | ₹-71 Cr |
| Mar2023 | ₹-33 Cr |
| Mar2022 | ₹-13 Cr |
| Mar2021 | ₹-14 Cr |
How is Deferred Tax Assets / Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-99 Cr | Negative | |
| Mar2024 | ₹-71 Cr | Negative | |
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹-13 Cr | Negative | |
| Mar2021 | ₹-14 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,290.7 Cr | -3.1% | 4% | 38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -3.1% |
4% |
38% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses